34 related articles for article (PubMed ID: 1585000)
1. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
[TBL] [Abstract][Full Text] [Related]
3. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
Engert A; Schiller P; Josting A; Herrmann R; Koch P; Sieber M; Boissevain F; De Wit M; Mezger J; Duhmke E; Willich N; Muller RP; Schmidt BF; Renner H; Muller-Hermelink HK; Pfistner B; Wolf J; Hasenclever D; Loffler M; Diehl V;
J Clin Oncol; 2003 Oct; 21(19):3601-8. PubMed ID: 12913100
[TBL] [Abstract][Full Text] [Related]
4. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
5. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
[TBL] [Abstract][Full Text] [Related]
6. Cancer of the oropharynx developed after radiotherapy and chemotherapy for Hodgkin's disease--a case report.
Mohiuddin MG; Sakai K; Tsuchida E; Inakoshi H
Radiat Med; 1992; 10(1):30-3. PubMed ID: 1585000
[TBL] [Abstract][Full Text] [Related]
7. Relapse of Hodgkin's disease after 10 years of complete remission: case report.
Mwanda OW; Othieno-Abinya N
East Afr Med J; 1998 Mar; 75(3):192-4. PubMed ID: 9640822
[TBL] [Abstract][Full Text] [Related]
8. Mediastinal osteosarcoma with extension to lungs in a patient treated for Hodgkin's disease.
Catanese J; Dutcher JP; Dorfman HD; Andres DF; Wiernik PH
Cancer; 1988 Nov; 62(10):2252-7. PubMed ID: 3052784
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin's disease primarily involving the oropharynx: case report and review of the literature.
Aloulou S; Farhat H; Bosq J; Vanel D; Ribrag V; Turhan AG; Girinsky T; Fermé C
Hematol J; 2002; 3(3):164-7. PubMed ID: 12111654
[TBL] [Abstract][Full Text] [Related]
10. Second cancer after Hodgkin's disease--the price of success?
Boice JD
J Natl Cancer Inst; 1993 Jan; 85(1):4-5. PubMed ID: 8416254
[No Abstract] [Full Text] [Related]
11. [Male secondary breast cancer after treatment for Hodgkin's disease. Case report and review of the literature].
Boussen H; Kochbati L; Besbes M; Dhiab T; Makhlouf R; Jerbi G; Gamoudi A; Benna F; Rahal K; Maalej M; Ben Ayed F
Cancer Radiother; 2000; 4(6):465-8. PubMed ID: 11191854
[TBL] [Abstract][Full Text] [Related]
12. Hypothermia and Hodgkin's disease: case report and review of the literature.
Meert AP; Berghmans T; Sculier JP
Acta Clin Belg; 2006; 61(5):252-4. PubMed ID: 17240740
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
